• Skip to primary navigation
  • Skip to main content

SAAMnow

Scientists Advancing Affordable Medicines

  • Upcoming Events
  • Past Workshops
    • 2022 Spring Scientific Workshop
    • 2019 Fall Scientific Workshop
    • 2019 Spring Scientific Workshop
    • 2018 Annual Scientific Workshop
  • Past Webinars
    • Statistical and Data Analysis Issues and Solutions for ANDAs and 505(b)(2) NDAs
    • Data Integrity in Bioequivalence Studies
    • Challenges and Issues in Meeting Regulatory Requirements for In Vitro Dissolution Testing 
    • Secrets to Successful Pre-IND Meetings for 505(b)(2) NDA Drug Development
    • In Silico Modeling Methods for Generic Drug Products: Applications and Expectations
    • 505(b)(2) Webinar Series: Session 3
    • 505(b)(2) Webinar Series: Session 2
    • 505(b)(2) Webinar Series: Session 1
  • About Us
  • Join
  • Contact Us

Main Content

Welcome!

Scientists Advancing Affordable Medicines, Inc. is a nonprofit 501(c)(6) organization that seeks to provide a dedicated platform for scientists to share cutting-edge research that facilitates the development of high-quality, affordable medicines, thereby improving their accessibility to patients. Because we are sharing approaches now for the affordable medicines of tomorrow, we have adopted the tradename SAAMnow.

About Us
President’s Letter

WEBINAR: Navigating the Whirlwind Surrounding N-Nitrosamine Impurities in APIs and Drug Products

October 1-2, 2025 | 8:30am -12:30 pm EDT

Bringing together scientists from industry, the FDA, the USP, and the IGBA, the workshop will focus on regulatory, scientific and technical challenges surrounding the presence of N-nitrosamine impurities in active pharmaceutical ingredients (APIs) and drug products. Participants will explore cutting-edge methods, regulatory updates, and research developments regarding N-nitrosamines.

The workshop consists of two half-day virtual sessions, each held in the morning (U.S. time), featuring four to five concise presentations by experts in the field (20–40 minutes each) followed by a panel discussion during which attendees can have their follow-up questions answered.

Register

Join SAAMnow

SAAMnow offers individuals the opportunity to potentially impact the availability of affordable medicines through cutting-edge research. SAAMnow is looking for individuals involved/interested in research & development, formulation/manufacturing science, analytical chemistry, clinical science, statistics, quality systems, regulatory science, marketing, and allied disciplines associated with the development, manufacturing, testing, and commercialization of high quality affordable medicines. Affordable medicines are broadly defined as those that take advantage of abbreviated regulatory filing pathways, resulting in development cost savings that can then be passed on to patients. Examples include conventional generic pharmaceuticals, biosimilars, and products filed via hybrid regulatory pathways, such as the 505(b)(2) route.

Our annual membership dues: $50.


Join Today

Thank You to Our Sponsors!

cipla
axis
diteba
biostudy-solutions

For more information about SAAMnow, contact us below.

Contact Us

Copyright © 2025 · SAAMnow